NASDAQ:TACT - TransAct Technologies Stock Price, News & Analysis

TransAct Technologies trades on the NASDAQ under the ticker symbol "TACT."

TransAct Technologies declared a quarterly dividend on Friday, August 2nd. Shareholders of record on Tuesday, August 20th will be paid a dividend of $0.09 per share on Monday, September 16th. This represents a $0.36 annualized dividend and a yield of 2.99%. The ex-dividend date is Monday, August 19th. View TransAct Technologies' Dividend History.

TransAct Technologies declared that its board has approved a share repurchase plan on Tuesday, March 6th 2018, which allows the company to repurchase $5,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its shares are undervalued.

TransAct Technologies Incorporated (NASDAQ:TACT) issued its earnings results on Wednesday, August, 7th. The technology company reported $0.02 EPS for the quarter. The technology company earned $11.35 million during the quarter. TransAct Technologies had a return on equity of 16.31% and a net margin of 8.85%. View TransAct Technologies' Earnings History.

TransAct Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for TransAct Technologies.

1 Wall Street analysts have issued 12 month price targets for TransAct Technologies' shares. Their forecasts range from $14.00 to $14.00. On average, they expect TransAct Technologies' stock price to reach $14.00 in the next twelve months. This suggests a possible upside of 16.3% from the stock's current price. View Analyst Price Targets for TransAct Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TransAct Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for TransAct Technologies.

News coverage about TACT stock has been trending negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. TransAct Technologies earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned news headlines about the technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for TransAct Technologies.

Some companies that are related to TransAct Technologies include Immersion (IMMR), RADCOM (RDCM), AstroNova (ALOT), Identiv (INVE), Key Tronic (KTCC), Interlink Electronics (LINK), IGO (IGOI), Hauppauge Digital (HAUP) and HTC (HTCXF).

Based on aggregate information from My MarketBeat watchlists, some companies that other TransAct Technologies investors own include Allena Pharmaceuticals (ALNA), REDHILL BIOPHAR/S (RDHL), Veru (VERU), Viking Therapeutics (VKTX), Palatin Technologies (PTN), Curaleaf (CURLF), Cerecor (CERC), Genocea Biosciences (GNCA), Sorrento Therapeutics (SRNE) and Viewray (VRAY).

TransAct Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (5.69%), BlackRock Inc. (3.78%), Cowen Prime Services LLC (3.56%), North Star Investment Management Corp. (1.65%), Municipal Employees Retirement System of Michigan (0.61%) and Connors Investor Services Inc. (0.41%). Company insiders that own TransAct Technologies stock include Andrew John Hoffman, Bart C Shuldman, David B Peters, Graham Y Tanaka, Haydee Olinger, John Dillon, Steven A Demartino, Thomas R Schwarz and Tracey S Chernay. View Institutional Ownership Trends for TransAct Technologies.

TACT stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC and Wells Fargo & Company MN. Company insiders that have sold TransAct Technologies company stock in the last year include David B Peters, Graham Y Tanaka, Thomas R Schwarz and Tracey S Chernay. View Insider Buying and Selling for TransAct Technologies.

TACT stock was purchased by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan, Cowen Prime Services LLC, Connors Investor Services Inc., HM Payson & Co., North Star Investment Management Corp., M&T Bank Corp, BlackRock Inc. and Renaissance Technologies LLC. Company insiders that have bought TransAct Technologies stock in the last two years include Haydee Olinger and John Dillon. View Insider Buying and Selling for TransAct Technologies.

Shares of TACT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TACT stock can currently be purchased for approximately $12.04.

TransAct Technologies has a market capitalization of $89.94 million and generates $54.59 million in revenue each year. TransAct Technologies employs 126 workers across the globe.View Additional Information About TransAct Technologies.

The official website for TransAct Technologies is http://www.transact-tech.com/.

TransAct Technologies' mailing address is ONE HAMDEN CENTER 2319 WHITNEY AVENUE SUITE 3B, HAMDEN CT, 06518. The technology company can be reached via phone at 203-859-6800 or via email at [email protected]